Company Overview: Q2 Metals Corp. (TSXV: QTWO) is a Canada-based mineral exploration company advancing the exploration of its approximately 86-square-kilometer Mia Lithium Project in the James Bay region of Quebec, Canada. The Company also holds two highly prospective gold projects in the goldfields of Queensland, Australia: the Big Hill Gold Project and the Titan Project. Cognition Therapeutics Inc.(NASDAQ: CGTX) is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. This Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks. 

Global Markets Wrap-Up

As of July 17, 2025, major U.S. equity indices posted positive week-to-date (WTD) performances, supported by broad-based sector strength. The S&P 500 edged up 0.60% to close at 6,297.36, while the NASDAQ Composite advanced 1.46% to 20,885.65, driven by continued momentum in the technology sector. The Russell 2000, which tracks small-cap stocks, also recorded a gain, rising 0.84% to end the week at 2,253.68.

In Canada, the S&P/TSX Venture Composite Index advanced 1.00% WTD to close at 791.66, extending its broader uptrend. Thursday’s session saw strength across technology, consumer non-cyclicals, financials, consumer cyclicals, industrials, and energy, providing near-term support and reinforcing pockets of bullish momentum. However, these gains were partially offset by weakness in the real estate, basic materials, and healthcare sectors. This sectoral divergence highlights ongoing investor caution, which is tempering the broader rally and signalling a selective risk-on approach despite the index’s recent resilience.